Not all researchers are convinced that the brain changes detected via MRI are robust enough to become a diagnostic tool. But ...

Dementia research has reached a major milestone: Alzheimer's disease is no longer untreatable, according to a landmark global ...

Medically reviewed by Smita Patel, DO Key Takeaways Anti-amyloid medications taken in early-stage Alzheimer’s may slow ...

The finding in human cerebrospinal fluid also raises the possibility of using meprin-β as an indicator of Alzheimer’s. This ...

In the last year, the Alzheimer’s community has seen a surge of developments — from new blood tests to new treatments — ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

Much of what we know about what causes Alzheimer’s disease – a type of dementia – can be credited to individuals with Down ...

Loved ones, caregivers and supporters of Wyomingites living with Alzheimer’s disease will come together Saturday, Oct. 10, ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

The study, published in Frontiers in Immunology, was conducted by researchers from Hofstra University and Northwell Health in New York.

Neuropacs™ Corp. today announced that its Co-Founder & Chief Scientific Officer, Dr. David Vaillancourt, will serve as a key scientific leader in a $22 million National Institutes of Health grant ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...